Show simple item record

dc.contributor.authorRegatieri, Caio V.
dc.contributor.authorBranchini, Lauren
dc.contributor.authorFujimoto, James G.
dc.contributor.authorDuker, Jay S.
dc.date.accessioned2012-10-15T14:53:01Z
dc.date.available2012-10-15T14:53:01Z
dc.date.issued2012-05
dc.identifier.issn0275-004X
dc.identifier.urihttp://hdl.handle.net/1721.1/73959
dc.descriptionAuthor Manuscript received 2012 June 22.en_US
dc.description.abstractBackground: A structurally and functionally normal choroidal vasculature is essential for retinal function. Therefore, a precise clinical understanding of choroidal morphology should be important for understanding many retinal and choroidal diseases. Methods: PUBMED ( http://www.ncbi.nlm.nih.gov/site...) was used for most of the literature search for this article. The criterion for inclusion of an article in the references for this review was that it included materials about both the clinical and the basic properties of choroidal imaging using spectral-domain optical coherence tomography. Results: Recent reports show successful examination and accurate measurement of choroidal thickness in normal and pathologic states using spectral-domain optical coherence tomography systems. This review focuses on the principles of the new technology that make choroidal imaging using optical coherence tomography possible and on the changes that subsequently have been documented to occur in the choroid in various diseases. Additionally, it outlines future directions in choroidal imaging. Conclusion: Optical coherence tomography is now proven to be an effective noninvasive tool to evaluate the choroid and to detect choroidal changes in pathologic states. Additionally, choroidal evaluation using optical coherence tomography can be used as a parameter for diagnosis and follow-up.en_US
dc.description.sponsorshipResearch to Prevent Blindness, Inc. (United States) (Unrestricted Grant)en_US
dc.description.sponsorshipNational Institutes of Health (U.S.) (Contract RO1-EY11289-25)en_US
dc.description.sponsorshipNational Institutes of Health (U.S.) (Contract R01-EY13178-10)en_US
dc.description.sponsorshipNational Institutes of Health (U.S.) (Contract R01-EY013516-07)en_US
dc.description.sponsorshipNational Institutes of Health (U.S.) (Contract R01-EY019029-02)en_US
dc.description.sponsorshipUnited States. Air Force Office of Scientific Research (Grant FA9550-10-1-0551)en_US
dc.description.sponsorshipUnited States. Air Force Office of Scientific Research (FA9550-10-1-0063)en_US
dc.language.isoen_US
dc.publisherLippincott Williams & Wilkinsen_US
dc.relation.isversionofhttp://dx.doi.org/10.1097/IAE.0b013e318251a3a8en_US
dc.rightsCreative Commons Attribution-Noncommercial-Share Alike 3.0en_US
dc.rights.urihttp://creativecommons.org/licenses/by-nc-sa/3.0/en_US
dc.sourcePubMed Centralen_US
dc.titleChoroidal Imaging Using Spectral-Domain Optical Coherence Tomographyen_US
dc.typeArticleen_US
dc.identifier.citationRegatieri, Caio V. et al. “Choroidal Imaging Using Spectral-Domain Optical Coherence Tomography.” Retina 32.5 (2012): 865–876.en_US
dc.contributor.departmentMassachusetts Institute of Technology. Department of Electrical Engineering and Computer Scienceen_US
dc.contributor.departmentMassachusetts Institute of Technology. Research Laboratory of Electronicsen_US
dc.contributor.mitauthorFujimoto, James G.
dc.relation.journalRetinaen_US
dc.eprint.versionAuthor's final manuscripten_US
dc.type.urihttp://purl.org/eprint/type/JournalArticleen_US
eprint.statushttp://purl.org/eprint/status/PeerRevieweden_US
dspace.orderedauthorsRegatieri, Caio V.; Branchini, Lauren; Fujimoto, James G.; Duker, Jay S.en
dc.identifier.orcidhttps://orcid.org/0000-0002-0828-4357
mit.licenseOPEN_ACCESS_POLICYen_US
mit.metadata.statusComplete


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record